Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2001
04/10/2001US6214597 CSAPK-3 protein and uses therefor
04/10/2001US6214595 Enzymatic polypeptide for utilization in screening bactericides; wound healing agents; for prevent of bacterial wound infections
04/10/2001US6214588 Polymerase holoenzyme; for use in design drugs that target eukaryotic parasites
04/10/2001US6214571 Method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosine phosphorylase deficient cells
04/10/2001US6214570 Separating high density lipoproteins from body fluids; incubate body fluid with porous carrier, precipitate polypeptides, incubate remaining body fluid with second porous carrier, separate the different lipoproteins
04/10/2001US6214569 Detecting therapeutic agents for treatment of nervous system disorders; incubate modulators and test compound, monitor reduction in the formation of peptide filaments in cells
04/10/2001US6214568 Monoclonal antibodies of isotype IgG which bind specifically to glutamate decarboxylase, and uses thereof
04/10/2001US6214567 Testing antitumor agents; obtain preferential human tissue and incubate with antitumor agent, evaluate propagtion of tumorous cells
04/10/2001US6214566 Screening for preferential compounds in sample; mixing test sample and squalane, incubate formed complex with immunoglobulin, incubate mix with indicator, detect immunoglobulin bound complexes
04/10/2001US6214565 Assay for disease related conformation of a protein and isolating same
04/10/2001US6214563 Such as in fluorescence assays in living cells; photon reducing agent is a dye such as tarazine
04/10/2001US6214562 Transcriptionally regualted G protein-coupled receptor
04/10/2001US6214561 Method for detecting biologically active compounds from compound libraries
04/10/2001US6214560 Analyte assay using particulate labels
04/10/2001US6214558 Diagnosing fetal genome mutation; insert nucleotide sequence probe in to sample, allow hybridization, wash sample, determine if adjustments exists in genome and whether they are indicative chromosomal mutation
04/10/2001US6214554 Chronic fatigue syndrome diagnosis
04/10/2001US6214553 Libraries of protein encoding RNA-protein fusions
04/10/2001US6214552 Assays for measuring nucleic acid damaging activities
04/10/2001US6214550 Methods of differentiating metastatic and non-metastatic tumors
04/10/2001US6214543 DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof
04/10/2001US6214541 Monitoring the activity of preferential immunoglobulins; incubate bound human papilloma virus with body fluid and preferential immunoglobulins, observe signal from bound proteins
04/10/2001US6214537 Amino acid sequences for the detection of preferential viral diseases
04/10/2001US6214536 Method of detecting lung disease
04/10/2001US6214535 Diagnosing cardiovascular disorders; obtain heart muscle tissue, detect hepatitis virus in tissues
04/10/2001US6214355 DbpA compositions
04/10/2001US6214348 Administering to the mammal a polypeptide comprising seq id no:2 in an amount sufficient to induce an immunological response to produce antibodies to seq id no:2
04/10/2001US6214346 Bactericides
04/10/2001US6214293 Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization
04/10/2001US6214291 For determining whether paint applied to a surface is oil base paint or latex base paint; kit comprises a housing that has a breakable tip reagent container filled with denatured alcohol
04/10/2001US6214221 Method and apparatus for purification of biological substances
04/10/2001US6214208 Dissociation by appyling voltage
04/10/2001US6214205 Determination of an analyte in a liquid medium
04/10/2001US6213943 Apparatus for signal transmission and detection using a contact device for physical measurement on the eye
04/10/2001US6213888 Golf club shaft
04/10/2001US6212950 Glass interlaced fuel system low current rheostat
04/10/2001US6212948 Apparatus and method to obtain representative samples of oil well production
04/10/2001US6212939 Uncoated microcantilevers as chemical sensors
04/10/2001CA2163151C Humanized and chimeric monoclonal antibodies that recognized epidermal growth factor receptor (egf-r). use diagnostic and therapeutic
04/10/2001CA2160321C Collection electrode (collectrode) for geo-electrochemical sampling
04/10/2001CA2081150C Use of antibody-containing preparations for immunosuppression
04/10/2001CA2076901C Kainate-binding, human cns receptors of the eaa2 family
04/10/2001CA2070647C Use of an anticoagulant as a diagnostic agent
04/10/2001CA2067233C Fibronectin binding peptide
04/05/2001WO2001024328A2 Method of converting an optical wavelength with an opto-electronic laser with integrated modulator
04/05/2001WO2001023895A2 Thrombotic episode risk assays using oxidized phospholipids
04/05/2001WO2001023894A1 Quantitative analysis and typification of subcellular particles
04/05/2001WO2001023893A2 Detection of hla-g
04/05/2001WO2001023891A1 High sensitive immunoassay
04/05/2001WO2001023890A1 Biosensor detector array
04/05/2001WO2001023889A1 Method of using one-dimensional and multi-dimensional nuclear magnetic resonance to identify compounds that interact with target biomolecules
04/05/2001WO2001023888A1 Addressable arrays using morphology dependent resonance for analyte detection
04/05/2001WO2001023886A1 Improved toxicity screening method
04/05/2001WO2001023885A1 Test device
04/05/2001WO2001023884A1 Methods for determining oils in seeds
04/05/2001WO2001023883A1 Chemical sensing system
04/05/2001WO2001023882A1 DETECTION OF POLYPEPTIDE FRAGMENTS AND MODIFIED FORMS OF α1-ANTITRYPSIN FOR EARLY DIAGNOSIS OF INFLAMMATION
04/05/2001WO2001023879A1 Liquid homogenizing unit and high speed liquid chromatograph equipped with the same
04/05/2001WO2001023878A1 System and method of assessing the structural properties of wooden members using ultrasound
04/05/2001WO2001023875A2 METHOD FOR DIAGNOSING THE LEVEL OF DETERIORATION OF AN NOx CATALYST LOCATED IN THE EXHAUST CHANNEL OF AN INTERNAL COMBUSTION ENGINE
04/05/2001WO2001023868A1 Pcb measurement in pork fat with nir
04/05/2001WO2001023867A1 Method and device for detecting a molecular recognition reaction
04/05/2001WO2001023866A1 Method and device for analysing nucleic acids immobilised on a support
04/05/2001WO2001023822A1 Fractal absorber for heat pipes with broad range heat radiation absorptivity
04/05/2001WO2001023617A1 Method for regulating cell growth and assays related thereto
04/05/2001WO2001023607A2 Multiplex pcr for detecting ehec infections
04/05/2001WO2001023605A2 Method and nucleic acids for determining the presence of micro-organisms specific to the brewing process
04/05/2001WO2001023602A1 Method for determining and modifying protein/peptide solubility
04/05/2001WO2001023598A1 41 human secreted proteins
04/05/2001WO2001023590A2 22196, a novel human aminopeptidase
04/05/2001WO2001023588A1 Human carboxypeptidases and polynucleotides encoding the same
04/05/2001WO2001023584A1 Human ubiquitin protease
04/05/2001WO2001023572A2 Polynucleotides and polypeptides encoded thereby
04/05/2001WO2001023571A1 Methods and compositions relating to sodium channel beta1a subunits
04/05/2001WO2001023570A2 Methods and compositions relating to sodium channel beta-1a subunits
04/05/2001WO2001023566A1 Novel human organic anion transporter-like proteins and polynucleotides encoding the same
04/05/2001WO2001023565A1 P-glycoproteins from macaca fascicularis and uses thereof
04/05/2001WO2001023554A1 The prv-1 gene and use thereof
04/05/2001WO2001023552A1 Human paralogue of a head trauma induced cytoplasmatic calcium binding protein
04/05/2001WO2001023551A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use
04/05/2001WO2001023550A2 Pca3 messenger rna species in benign and malignant prostate tissues
04/05/2001WO2001023547A1 26 human secreted proteins
04/05/2001WO2001023546A1 37 human secreted proteins
04/05/2001WO2001023459A1 Particle structures with receptors for analyte detection
04/05/2001WO2001023425A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis
04/05/2001WO2001023418A1 YphC
04/05/2001WO2001023414A2 Immunologically significant herpes simplex virus antigens
04/05/2001WO2001023412A2 Methods of screening for agents which inhibit aggregation of polypeptides
04/05/2001WO2001023409A2 38 human secreted proteins
04/05/2001WO2001023402A1 43 human secreted proteins
04/05/2001WO2001023388A2 AMINO SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES
04/05/2001WO2001023387A2 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES
04/05/2001WO2001023082A2 Biomolecular attachment sites on microelectronic arrays
04/05/2001WO2001022984A1 Hcv e2 protein binding agents for treatment of hepatitis c virus infection
04/05/2001WO2001022981A1 Treatment of diabetic nephropathy and microalbuminuria
04/05/2001WO2001022922A2 Engineering antibodies that bind irreversibly
04/05/2001WO2001022916A2 Novel hev antigenic peptide and methods
04/05/2001WO2001022816A1 MODULATION OF ηδ T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS
04/05/2001WO2001022811A1 Transgenic animal expressing a multiple mutated form of presenilin 1
04/05/2001WO2001011369A8 Cancer treatments and diagnostics utilizing rad51 related molecules and methods
04/05/2001WO2001007915A3 Layered device with capture regions for cellular analysis